These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34514571)

  • 1. Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions.
    Hui M; Uppin SG; Kumar KK; Radhika S; Chandrasekhar P; Rao KN
    Turk Patoloji Derg; 2022; 38(1):9-15. PubMed ID: 34514571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
    Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
    Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 expression in giant cell-containing lesions of bone and soft tissue.
    de la Roza G
    Arch Pathol Lab Med; 2011 Jun; 135(6):776-9. PubMed ID: 21631272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
    Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
    J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained.
    Maues De Paula A; Vasiljevic A; Giorgi R; Gomez-Brouchet A; Aubert S; Leroy X; Duval H; de Pinieux G; Bouvier C
    Virchows Arch; 2014 Oct; 465(4):487-94. PubMed ID: 25100342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANK signalling in bone lesions with osteoclast-like giant cells.
    Won KY; Kalil RK; Kim YW; Park YK
    Pathology; 2011 Jun; 43(4):318-21. PubMed ID: 21532526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
    Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
    Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
    Wang X; Wu N; Zhang RS; Wei X; Ji RH; Ma HH; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):116-121. PubMed ID: 32074722
    [No Abstract]   [Full Text] [Related]  

  • 13. Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours.
    Cleven AHG; Schreuder WH; Groen E; de Lange J; Briaire-de Bruijn IH; Bovée JVMG
    Virchows Arch; 2022 Oct; 481(4):671-675. PubMed ID: 35612673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63 as a prognostic marker for giant cell tumor of bone.
    Yanagisawa M; Kakizaki H; Okada K; Torigoe T; Kusumi T
    Ups J Med Sci; 2013 Mar; 118(1):23-8. PubMed ID: 23033898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cell tumor of bone express p63.
    Dickson BC; Li SQ; Wunder JS; Ferguson PC; Eslami B; Werier JA; Turcotte RE; Kandel RA
    Mod Pathol; 2008 Apr; 21(4):369-75. PubMed ID: 18311114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
    Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C
    Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience.
    Hammas N; Laila C; Youssef AL; Hind el F; Harmouch T; Siham T; Afaf A
    Diagn Pathol; 2012 Sep; 7():130. PubMed ID: 23016917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
    Lee CH; Espinosa I; Jensen KC; Subramanian S; Zhu SX; Varma S; Montgomery KD; Nielsen TO; van de Rijn M; West RB
    Mod Pathol; 2008 May; 21(5):531-9. PubMed ID: 18192965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.